We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Primary Care

Journal Scan / Case Study · August 26, 2020

Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment

Annals of Internal Medicine


Additional Info

Annals of Internal Medicine
Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report
Ann. Intern. Med 2020 Aug 04;[EPub Ahead of Print], E Brailovski, RB Kim, D Juurlink

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading